🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HILLCLIMBER is a randomized, controlled, open-label phase II trial of moder...
Status
Completed
Location
Northwestern University
Start Date
2016-11
Trial ID
NCT02841774
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Olostar Table...
Status
Active Not Recruiting
Location
Severance Hospital
Start Date
2022-06-20
Trial ID
NCT05411887
Treatments Being Tested
This study assessed the safety and efficacy of generic Rosuvastatin in redu...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT03516955
Treatments Being Tested
To investigate the efficacy and safety after administration of HCP1105 in h...
Status
Unknown
Location
Euljii General Hospital
Start Date
2014-10
Trial ID
NCT02551172
Treatments Being Tested
A phase Ⅲ, multi-center, randomized, double-blinded, active comparator, fac...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-04
Trial ID
NCT02749994
Treatments Being Tested
The purpose of this study is to compare the effects of pravastatin and rosu...
Status
Unknown
Location
Yokohama City University Medical Center
Start Date
2011-03
Trial ID
NCT01325818
Treatments Being Tested
Aim: The role of surgical castration and rosuvastatin treatment on lipid pr...
Status
Completed
Location
National Cancer Institute
Start Date
2019-01-15
Trial ID
NCT04776889
Treatments Being Tested
This randomized, open label, parallel-group study is designed to investigat...
Status
Unknown
Location
Beijing Anzhen Hospital
Start Date
2012-01
Trial ID
NCT01646307
Treatments Being Tested
The primary objective is to evaluate the efficacy of rosuvastatin therapy o...
Status
Completed
Location
Research site
Start Date
2008-12
Trial ID
NCT00815659
Treatments Being Tested
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2022-01-01
Trial ID
NCT06225635
Treatments Being Tested